New French fee payment system puts industry at arm's length
This article was originally published in Scrip
Executive Summary
In the first concrete step towards shaking up the French drug regulatory framework, the medicines agency Afssaps has published details of the new system under which industry taxes and fees will be paid to the state, rather than directly to the agency.